ERBB2 and neoplasm: According to consensus/majority scoring, the 7 tumours scored as 0, were subsequently divided into HER2 negative (1/50; 2%) and HER2 ultralow (6/50; 12%), the latter defined as evident focal staining in less than 10% of cells.